Literature DB >> 17966977

Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size.

David Heber1, Navindra P Seeram, Holly Wyatt, Susanne M Henning, Yanjun Zhang, Lorraine G Ogden, Mark Dreher, James O Hill.   

Abstract

The consumption of pomegranate juice (PJ), a rich source of antioxidant polyphenols, has grown tremendously due to its reported health benefits. Pomegranate extracts, which incorporate the major antioxidants found in pomegranates, namely, ellagitannins, have been developed as botanical dietary supplements to provide an alternative convenient form for consuming the bioactive polyphenols found in PJ. Despite the commercial availability of pomegranate extract dietary supplements, there have been no studies evaluating their safety in human subjects. A pomegranate ellagitannin-enriched polyphenol extract (POMx) was prepared for dietary supplement use and evaluated in two pilot clinical studies. Study 1 was designed for safety assessment in 64 overweight individuals with increased waist size. The subjects consumed either one or two POMx capsules per day providing 710 mg (435 mg of gallic acid equivalents, GAEs) or 1420 mg (870 mg of GAEs) of extracts, respectively, and placebo (0 mg of GAEs). Safety laboratory determinations, including complete blood count (CBC), chemistry, and urinalysis, were made at each of three visits. Study 2 was designed for antioxidant activity assessment in 22 overweight subjects by administration of two POMx capsules per day providing 1000 mg (610 mg of GAEs) of extract versus baseline measurements. Measurement of antioxidant activity as evidenced by thiobarbituric acid reactive substances (TBARS) in plasma were measured before and after POMx supplementation. There was evidence of antioxidant activity through a significant reduction in TBARS linked with cardiovascular disease risk. There were no serious adverse events in any subject studied at either site. These studies demonstrate the safety of a pomegranate ellagitannin-enriched polyphenol dietary supplement in humans and provide evidence of antioxidant activity in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17966977     DOI: 10.1021/jf071689v

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  33 in total

1.  Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.

Authors:  Matthew B Rettig; David Heber; Jiabin An; Navindra P Seeram; Jian Y Rao; Huiren Liu; Tobias Klatte; Arie Belldegrun; Aune Moro; Susanne M Henning; Deqiong Mo; William J Aronson; Allan Pantuck
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

2.  Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms.

Authors:  Andrea M Vincent; Koichi Kato; Lisa L McLean; Mary E Soules; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

3.  Acute effects of pomegranate extract on postprandial lipaemia, vascular function and blood pressure.

Authors:  Aarati Susan Mathew; Gabriella M Capel-Williams; Sarah E E Berry; Wendy L Hall
Journal:  Plant Foods Hum Nutr       Date:  2012-12       Impact factor: 3.921

4.  Inhibition of nonenzymatic protein glycation by pomegranate and other fruit juices.

Authors:  Pamela Garner Dorsey; Phillip Greenspan
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

5.  The use of LeptiCore in reducing fat gain and managing weight loss in patients with metabolic syndrome.

Authors:  Dieudonne Kuate; Blanche C O Etoundi; Boris K G Azantsa; Anne-Pascale N Kengne; Judith L Ngondi; Julius E Oben
Journal:  Lipids Health Dis       Date:  2010-02-19       Impact factor: 3.876

6.  Pomegranate juice and pomegranate extract do not impair oral clearance of flurbiprofen in human volunteers: divergence from in vitro results.

Authors:  M J Hanley; G Masse; J S Harmatz; M H Court; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  2012-10-10       Impact factor: 6.875

7.  Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects.

Authors:  Navindra P Seeram; Yanjun Zhang; Rodney McKeever; Susanne M Henning; Ru-po Lee; Marc A Suchard; Zhaoping Li; Steve Chen; Gail Thames; Alona Zerlin; Martha Nguyen; David Wang; Mark Dreher; David Heber
Journal:  J Med Food       Date:  2008-06       Impact factor: 2.786

8.  Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease.

Authors:  Lalida Rojanathammanee; Kendra L Puig; Colin K Combs
Journal:  J Nutr       Date:  2013-03-06       Impact factor: 4.798

9.  Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents.

Authors:  Monica Viladomiu; Raquel Hontecillas; Pinyi Lu; Josep Bassaganya-Riera
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-30       Impact factor: 2.629

10.  In Vitro and In Vivo Antibacterial Activity of Punica granatum Peel Ethanol Extract against Salmonella.

Authors:  Jang-Gi Choi; Ok-Hwa Kang; Young-Seob Lee; Hee-Sung Chae; You-Chang Oh; Obiang-Obounou Brice; Min-San Kim; Dong-Hwan Sohn; Hun-Soo Kim; Hyun Park; Dong-Won Shin; Jung-Rae Rho; Dong-Yeul Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.